-
Research Progress of Baihe Gujin Decoction in the Treatment of Lung Cancer
23 Apr 2024 17:30 GMT
… cell lung cancer (NSCLC) and small cell lung cancer ( … Lung Cancers
Clinical Study of Baihe Gujin Decoction in the Treatment of Lung Cancer … lung cancer patients. For instance, Baihe Gujin decoction with vinorelbine … lung cancer. In the study on 84 lung cancer …
-
Cost-Effectiveness of First-Line Atezolizumab versus Chemotherapy in Non-Small-Cell Lung Cancer Patients Ineligible for Platinum-Containing Regimens
11 Apr 2024 16:52 GMT
… for non-small-cell lung cancer (NSCLC) patients ineligible … 7,8 of all lung cancers cases, with nearly … proportion of gemcitabine and vinorelbine usage. Consequently, we … small-cell lung cancer: a cost-effectiveness analysis. Translational Lung Cancer Res. …
-
Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer or HR Positive, HER2 Negative Breast Cancer
04 Mar 2024 10:29 GMT
… nonsquamous non-small cell lung cancer (NSCLC) who … chemotherapy (eribulin, capecitabine, vinorelbine or gemcitabine) in patients … Small Cell Lung Cancer
Nearly 500,000 lung cancer cases were … References:
1 Cancer.net. Lung Cancer – Non-Small Cell: Statistics …
-
Alectinib Significantly Improves DFS Vs Chemo in Resected ALK+ NSCLC
23 Apr 2024 22:30 GMT
… ALK-positive non–small cell lung cancer (NSCLC), according to … MD, from Guang‑dong Lung Cancer Institute, Guangdong Provincial People’s … mg/m2 plus vinorelbine at 25 mg/ … with ALK-positive early-stage lung cancer. News release. Genentech. April …
-
Global Lung Cancer Drugs Market Forecast 2024-2033 – Market Size, Drivers, Trends, And Competitors
27 Dec 2023 16:45 GMT
… .
Lung Cancer Drugs Market Segments
• By Drugs: Gemzar, Paraplatin, Taxotere, Navelbine, … lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Small cell lung cancer … is a type of lung cancer that …
-
Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches
21 Dec 2023 04:45 GMT
… lung cancers. The two broad histological subtypes of lung cancer are small cell lung cancer … targeted delivery to lung tumors is a promising … 47;d) of oral vinorelbine (Navelbine®oral, NVBo) is … -small-cell lung cancer with daily oral vinorelbine–a Phase …
-
Global Lung Cancer Drugs Market Forecast 2023-2032 – Market Size, Drivers, Trends, And Competitors
28 Sep 2023 16:30 GMT
… lung cancer (SCLC), Non-small cell lung cancer … Navelbine, Avastin, Tarceva, Iressa, Other Drugs
• By Geography: The global lung cancer … treat lung cancer. Lung cancer … lung cancer (SCLC) and non-small cell lung cancer (NSCLC).
Read More On The Lung Cancer …
-
Alectinib Significantly Improves Disease-Free Survival in ALK-Positive NSCLC
20 Apr 2024 22:35 GMT
… ALK-positive non–small cell lung cancer (NSCLC) showed significant improvement following … 75 mg/m2 and vinorelbine 25 mg/m2 on … ALK-positive non–small-cell lung cancer. N Engl J Med. 2024 …
-
Atezolizumab monotherapy bests single-agent chemotherapy among patients with advanced non-small-cell lung cancer
05 Sep 2023 16:23 GMT
… or metastatic non-small-cell lung cancer (NSCLC), pivotal first- … or single-agent chemotherapy (vinorelbine [oral or intravenous] or … with non-small-cell lung cancer ineligible for treatment with … , advanced, non-small-cell lung cancer, The Lancet, Prof Siow …
-
FDA Approves Alectinib to Treat Patients With ALK-Positive NSCLC
19 Apr 2024 21:32 GMT
… Positive Non-Small Cell Lung Cancer
ClinicalTrials.gov ID: … with early-stage lung cancer undergo testing for … a combination of cisplatin, vinorelbine, gemcitabine, and pemetrexed, … Positive Non-Small Cell Lung Cancer.ClinicalTrials.gov identifier: NCT03456076 …